StockTrendNews (STN) Exclusive:Alseres Pharmaceuticals, Inc.
x
EBITDA for Boston Life Sciences Reaches Five Year High
Stock Quote:(N/A:ALSE)
09/02/2009
0.00
N/A
N/A
0
EBITDA for Boston Life Sciences Reaches Five Year High
Last
Price Change
% Chg
Volume
New York, NY, September 2, 2009-EbitdaEXTRA reports that negative EBITDA for Boston Life Sciences, Inc. (NASDAQ:ALSE) for its quarter ended June 30, 2009 was $(1,965,260), a 65% improvement over the y ... read full story
Futures fell off their highs in the premarket after the December trade deficit was reported to have widened to $40.2 billion from $36.4 billion in November on a sharp gain in imports. That was much higher than the expected deficit of $36.8 billion. F ... read full story
N/A 
